BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8523092)

  • 1. Syncope as the initial presentation of nasopharyngeal carcinoma.
    Wang CH; Ng SH
    J Neurooncol; 1995; 25(1):73-5. PubMed ID: 8523092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy.
    Daoud J; Toumi N; Bouaziz M; Ghorbel A; Jlidi R; Drira MM; Frikha M
    Eur J Cancer; 2003 Nov; 39(16):2349-54. PubMed ID: 14556927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving prognosis by simultaneous but not sequential radiochemotherapy: results of 2 randomized studies on nasopharyngeal carcinoma].
    Fietkau R
    Strahlenther Onkol; 1999 May; 175(5):248-50. PubMed ID: 10356617
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
    Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
    Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study.
    Fountzilas G; Tolis C; Kalogera-Fountzila A; Karanikiotis C; Bai M; Misailidou D; Samantas E; Athanassiou E; Papamichael D; Tsekeris P; Catodritis N; Nicolaou A; Plataniotis G; Makatsoris T; Papakostas P; Zamboglou N; Daniilidis J
    Strahlenther Onkol; 2005 Apr; 181(4):223-30. PubMed ID: 15827691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
    J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
    Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
    J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
    Lin Q; Yang RS; Sun L; Li YM; Wang LC; Dai MM; Luo ZM; Zhao L; Wu H
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):356-9. PubMed ID: 22883456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The standard to come: systemic therapies for systemic disease.
    Vokes EE; Liebowitz D
    Cancer J Sci Am; 1995; 1(3):184-6. PubMed ID: 9166473
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy.
    Cheng SH; Jian JJ; Tsai SY; Yen KL; Chu NM; Chan KY; Tan TD; Cheng JC; Leu SY; Hsieh CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1323-30. PubMed ID: 11121629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimodality treatment of nasopharyngeal carcinoma].
    Tanaka J; Inuyama Y; Fujii M; Takaoka T; Hosoda H; Kohno N
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1789-96. PubMed ID: 2439016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction Methotrexate, Cisplatin, and 5-Fluorouracil Versus Cisplatin and 5-Fluorouracil Followed by Radiotherapy in Pediatric Nasopharyngeal Carcinoma: A Retrospective Analysis in a Tertiary Cancer Center.
    Al Mousa A; Abu-Hijlih R; Salem A; Sultan I; Mula-Hussain L; Ismael T; Mohamad I
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e437-e442. PubMed ID: 28816803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.